Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Naomi Hoenisch Gravel Clear advanced filters
  • Here, Heitmann et al. report results from a Phase I/II trial evaluating CoVac-1, a peptide-based T-cell activator, in patients with B-cell deficiency, demonstrating potent induction of SARS-CoV-2-specific T-cell responses along with a favorable safety profile.

    • Jonas S. Heitmann
    • Claudia Tandler
    • Juliane S. Walz
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-10
  • MS-based immunopeptidomics provides direct evidence for HLA peptide-antigen presentation, which is indispensable for therapeutic use. Here the authors present an ion mobility MS-based immunopeptidome workflow, largely expand benign reference databases and enables next generation tumor antigen discovery.

    • Naomi Hoenisch Gravel
    • Annika Nelde
    • Juliane S. Walz
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-12